Next Article in Journal
Extraction and Characterization of Tamarind (Tamarind indica L.) Seed Polysaccharides (TSP) from Three Difference Sources
Next Article in Special Issue
Aza-Michael Mono-addition Using Acidic Alumina under Solventless Conditions
Previous Article in Journal
Photocatalytic Activities of Copper Doped Cadmium Sulfide Microspheres Prepared by a Facile Ultrasonic Spray-Pyrolysis Method
Previous Article in Special Issue
Solid Phase Formylation of N-Terminus Peptides
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

A New One-Pot Synthesis of Quinoline-2-carboxylates under Heterogeneous Conditions

by
Serena Gabrielli
,
Alessandra Giardinieri
,
Susanna Sampaolesi
,
Roberto Ballini
and
Alessandro Palmieri
*
Green Chemistry Group, Chemistry Division, School of Science and Technology, University of Camerino, via S. Agostino 1, 62032 Camerino, Italy
*
Author to whom correspondence should be addressed.
Molecules 2016, 21(6), 776; https://doi.org/10.3390/molecules21060776
Submission received: 24 May 2016 / Revised: 7 June 2016 / Accepted: 8 June 2016 / Published: 15 June 2016

Abstract

:
Quinoline-2-carboxylates are an important subclass of quinoline derivatives largely present in a variety of biologically active molecules, as well as useful ligands in metal-catalyzed reactions. Herein, we present a new one-pot protocol for synthesizing this class of derivatives starting from β-nitroacrylates and 2-aminobenzaldehydes. In order to optimize the protocol, we investigated several reaction conditions, obtaining the best results using the 2-tert-Butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine (BEMP) as solid base, in acetonitrile. Finally, we demonstrated the generality of our approach over several substrates which led to synthesize a plethora of functionalized quinolines-2-carboxylate derivatives in good overall yields.

Graphical Abstract

1. Introduction

Quinoline constitutes one of the most important nitrogen-containing heterocyclic compounds possessing several biological activities such as anti-bacterial, anti-fungal, anti-malarial, anti-convulsant, anti-inflammatory, anthelmintic, cardiotonic and analgesic [1]. In addition, the quinolinic nucleus is largely occurring in natural compounds and deeply investigated as building blocks for synthesizing highly functionalized materials [2,3]. In particular, quinoline-2-carboxylates play a predominant role as precursor of biologically active molecules [4,5,6,7,8] and as useful ligands in metal-catalyzed reactions [9,10]. Due to their importance, over the years, a variety of synthetic methodologies have been reported in the literature, which can be classified (Scheme 1) in: (i) oxidative processes, starting from the corresponding 2-methyl or 2-carbonyl quinolines [11,12]; (ii) hydrolytic reactions of cyano precursors [13]; (iii) metal-catalyzed cyclization, starting from N-aryl glycine derivatives or iminoethyl glyoxylates [14,15]; (iv) one-pot reduction-cyclization processes of 2-acylnitroarenes with α-oxoesters [16]; (v) carboxylation reactions of 2-chloro quinoline derivatives [17]; and (vi) the historical Doebner-Von Miller protocol [18].
Nevertheless, several of the reported procedures present some limitations such as restricted applicability (only few examples were reported) [11,12,13,18], low overall yields [16] and harsh reaction conditions [17]. Hence, new simple and general protocols for synthesizing these derivatives would surely be welcome. In this context, following our studies on the chemistry of β-nitroacrylates as valuable precursors of heterocycle systems [19,20,21,22,23,24,25,26,27], we propose their application as strategic starting materials, in combination with 2-aminobenzaldheydes, for synthesizing quinoline-2-carboxylates. The idea was to develop a new one-pot process involving four different reactions: (i) an aza-Michael addition between the 2-aminobenzaldheydes 1 and β-nitroacrylates 2; followed by (ii) an intramolecular Henry reaction to give the benzopiperidines 3; (iii) elimination of water; and (iv) nitrous acid elimination to provide the aromatization of the piperidine core, and thus the formation of title targets 4 (Scheme 2).

2. Results and Discussion

In order to study the reaction, we first synthesized the starting materials (Scheme 3). 2-Aminobenzaldheydes were prepared from the corresponding alcohols or nitro precursors [28,29], while β-nitroacrylates were synthesized by the Henry reaction-elimination process, starting from nitroalkanes and alkyl glyoxalates [30,31].
Once the starting materials were prepared, we switched our attention to optimize the process. Thus, first we studied the “aza-Michael-Henry domino process” between 2-aminobenzaldheyde 1a and ethyl-3-nitropent-2-enoate 2a (Table 1). Based on our previous experiences, we started testing the reaction under promoter-free and solvent-free conditions and, after a series of trials, the best result was obtained using a slight excess of 2a (1.1 equivalent) at 70 °C (3aa, 66%, entry 7, the presence of solvents or bases makes the reaction unproductive entry 9–12).
Successively, we studied the conversion of 3aa into 4aa (Table 2) and, after deep screening in terms of bases, solvents and temperature, we found the best yield of 4aa (86%, entry 8) at 50 °C, in acetonitrile using 1.25 equivalents of BEMP on polymer [32].
At that point, in order to achieve a one-pot process, we combined the two steps obtaining the quinoline 4aa in 58% of overall yield (Scheme 4).
Finally, with the aim to demonstrate the generality of our method, we tested our reaction conditions on a wide range of 2-aminobenzaldheydes 1 and β-nitroacrylates 2. In all cases, the products were obtained in moderate to good overall yields (37%–64%), even in the presence of a variety of functionalities (Scheme 5).

3. Conclusions

In conclusion, we developed a new general and valuable one-pot procedure for synthesizing an important class of quinolines such as quinoline-2-carboxylates. In our approach, it was possible to prepare title compounds in good overall yields, introducing different substituent in 3-position as well as in the benzene ring. Furthermore, the mildness of our reaction conditions allowed preserving several functionalities such as ester, cyano, chlorine, fluorine and carbon–carbon double bond. In addition, the use of supported BEMP enabled us to minimize the use of materials, avoiding any complex aqueous work-up, with evident advantages from a sustainable point of view. Finally, we still demonstrated the usefulness of β-nitroacrylates as a valuable precursor of heterocyclic systems.

4. Experimental Section

4.1. General Section

1H-NMR were recorded at 400 MHz on a VarianMercury Plus 400. 13C-NMR were recorded at 100 MHz. IR spectra were recorded with a PerkineElmer Paragon 500 FT-IR. Mass spectra were performed on a GC/MS system by means of the EI technique (70 eV). Microanalyses were performed with a CHNS-O analyzer Model EA 1108 from Fisons Instruments.

4.2. Chemistry Section

General Procedure for the Preparation of Compounds 4
A mixture of 2-aminobenzaldheydes 1 (1 mmol) and β-nitroacrylates 2 (1.1 mmol) was stirred, under solvent-free conditions, at 70 °C for 18 h. Then, after that the temperature was diminished at 50 °C, acetonitrile (10 mL) and PS-BEMP (1.25 mmol, 0.570 mg) were added, and the resulting solution was stirred at 50 °C for further 24 h. Finally, the resin was filtered off washing with fresh EtOAc (10 mL) and the crude products 4, obtained after removal of the solvent at reduced pressure, were purified by flash chromatography column (hexane–ethyl acetate 9:1).
Compound 4aa. Pale yellow oil. IR (cm−1, neat): 1063, 1160, 1458, 1619, 1727, 2959. 1H-NMR (CDCl3, 400 MHz) δ: 1.34 (t, 3H, J = 7.7 Hz), 1.46 (t, 3H, J = 7.3 Hz), 3.01 (q, 2H, J = 7.7 Hz), 4.53 (q, 2H, J = 7.3 Hz), 7.53–7.60 (m, 1H), 7.65–7.72 (m, 1H), 7.78 (d, 1H, J = 8.1 Hz), 8.04 (s, 1H), 8.16 (d, 1H, J = 8.5 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.5, 15.4, 25.9, 62.2, 127.2, 128.2, 129.1, 129.5, 130.0, 135.6, 136.4, 146.0, 150.7, 167.1. GC-MS (70 eV): m/z: 229 ([M+], 29), 200 (83), 182 (14), 157 (39), 156 (99), 155 (63), 154 (100), 128 (34). Anal. Calcd. for C14H15NO2 (229.28): C, 73.34; H, 6.59; N, 6.11. Found: C, 73.39; H, 6.62; N, 6.08.
Compound 4ab. Pale yellow oil. IR (cm−1, neat): 1073, 1171, 1459, 1610, 1728, 2952. 1H-NMR (CDCl3, 400 MHz) δ: 0.9 (t, 3H, J = 7.3 Hz), 1.34–1.41 (m, 4H), 1.47 (t, 3H, J = 7.3 Hz), 1.65–1.74 (m, 2H), 2.96–2.99 (m, 2H), 4.53 (q, 2H, J = Hz 7.3), 7.55–7.60 (m, 1H), 7.67–7.72 (m, 1H), 7.79 (d, 1H, J = 8.1 Hz), 8.04 (s, 1H), 8.175 (d, 1H J = 8.5 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.1, 14.4, 22.6, 30.1, 31.8, 32.7, 62.1, 127.1, 128.1, 129.0, 129.4, 130, 134.3, 137.1, 146.0, 151.0, 167.1. GC-MS (70 eV): m/z: 271 ([M+], 25), 245 (68), 228 (72), 224 (44), 199 (14), 198 (96), 196 (26), 182 (35), 168 (38), 166 (29), 156 (22), 155 (20), 154 (100), 143 (72), 142 (43), 141 (15), 140 (19), 132 (14), 115 (38). Anal. Calcd. for C17H21NO2 (271.36): C, 75.25; H, 7.80; N, 5.16. Found: C, 75.29; H, 7.77; N, 5.13.
Compound 4ac. Pale yellow oil. IR (cm−1, neat): 1069, 1167, 1455, 1615, 1722, 2955. 1H-NMR (CDCl3, 400 MHz) δ: 0.84–0.92 (m, 3H), 1.23–1.44 (m, 6H), 1.59–1.73 (m, 4H), 1.74–1.86 (m, 2H), 1.89–2.11 (m, 4H), 2.88–2.94 (m, 2H), 5.51–5.58 (m, 1H), 7.53–7.58 (m, 1H), 7.71–7.75 (m, 1H), 7.77 (d, 1H, J = 8.1 Hz), 8.02 (s, 1H), 8.17 (d, 1H, J = 8.5 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.3, 22.8, 24.1, 29.5, 31.4, 31.9, 32.8, 32.9, 79.4, 127.2, 128.1, 128.9, 129.6, 129.8, 133.7, 137.2, 145.8, 151.5, 167.2. GC-MS (70 eV): m/z: 325 ([M+], 4), 257(14), 256 (73), 238 (14), 213 (18), 212 (100), 200 (20), 182 (17), 168 (19), 157 (16), 155 (26), 143 (55), 142 (61), 115(20). Anal. Calcd. for C21H27NO2 (325.45): C, 77.50; H, 8.36; N, 4.30. Found: C, 77.55; H, 8.39; N, 4.27.
Compound 4ad. Pale yellow oil. IR (cm−1, neat): 1074, 1179, 1436, 1615, 1730, 2949. 1H-NMR (CDCl3, 400 MHz) δ: 1.46 (t, 3H, J = 7.3 Hz), 1.70–1.76 (m, 4H), 2.31–2.39 (m, 2H), 2.91–3.02 (m, 2H), 3.65 (s, 3H), 4.50 (q, 2H, J = 7.3 Hz), 7.57 (t, 1H, J = 7.3 Hz), 7.68 (t, 1H, J = 7.3 Hz), 7.77 (d, 1H, J = 8.1 Hz), 8.02 (s, 1H), 8.15 (d, 1H, J = 8.5 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.5, 24.9, 30.8, 32.6, 34.0, 51.8, 62.3, 127.2, 128.3, 129.0, 129.7, 130.0, 133.8, 137.4, 146.0, 150.5, 167.0, 174.1. GC-MS (70 eV): m/z: 315([M+], 30), 286 (68), 284 (29), 270 (18), 242 (28), 236 (21), 228 (81), 182 (61), 180 (29), 170 (14), 168 (42), 167 (44), 156 (14), 155(22), 154 (100), 143 (52), 142 (22), 127 (14), 115 (27). Anal. Calcd. for C18H21NO4 (315.37): C, 68.55; H, 6.71; N, 4.44. Found: C, 68.59; H, 6.68; N, 4.47.
Compound 4ae. Pale yellow oil. IR (cm−1, neat): 1027, 1236, 1456, 1659, 1716, 2245, 2933. 1H-NMR (CDCl3, 400 MHz) δ: 1.47 (t, 3H, J = 7.3 Hz), 1.71–1.93 (m, 4H), 2.40 (t, 2H, J = 6.8 Hz), 3.03 (t, 2H, J = 7.7 Hz), 4.53 (q, 2H, J = 7.3 Hz), 7.59 (t, 1H, J = 6.8 Hz), 7.71 (t, 1H, J = 7.3 Hz), 7.79 (d, 1H, J = 8.12 Hz), 8.04 (s, 1H), 8.17 (d, 1H J = 8.1 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.5, 17.3, 25.4, 30.4, 32.1, 62.4, 119.7, 127.2, 128.5, 129.0, 129.9, 130.0, 133.3, 137.5, 146.2, 150.0, 166.9. GC-MS (70 eV): m/z: 282 ([M+], 9), 253 (29), 228 (34), 209 (38), 209 (38), 182 (19), 170 (23), 168 (48), 154 (73), 143 (100), 142 (18), 140 (18), 115 (33), 91 (15). Anal. Calcd. for C17H18N2O2 (282.34): C, 72.32; H, 6.43; N, 9.92. Found: C, 72.36; H, 6.47; N, 9.89.
Compound 4af. Pale yellow oil. IR (cm−1, neat): 1072, 1162, 1460, 1617, 1720, 2958. 1H-NMR (CDCl3, 400 MHz) δ: 0.89–1.03 (m, 6H), 1.46 (d, 3H, J = 6.4 Hz), 1.66–1.79 (m, 3H), 1.80–1.93 (m, 1H), 2.93 (dt, 2H, J = 7.7, 2.1 Hz), 5.19–5.31 (m, 1H), 7.58 (t, 1H, J = 8.1 Hz), 7.71 (t, 1H, J = 8.1 Hz), 7.79 (d, 1H, J = 8.1 Hz), 8.05 (s, 1H), 8.24 (d, 1H, J = 8.1 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 10.2, 14.3, 19.8, 24.8, 29.1, 35.0, 74.8, 127.5, 128.2, 129.0, 129.8, 130.3, 133.6, 137.8, 146.0, 151.6, 167.1. GC-MS (70 eV): m/z: 271 ([M+], 8), 215(20), 214 (100), 200 (20), 198 (17), 182 (14), 170 (59), 168 (63), 154 (28), 143 (93), 143 (24), 115 (21), 41 (18), 29(19). Anal. Calcd. for C17H21NO2 (271.36): C, 75.25; H, 7.80; N, 5.16. Found: C, 75.21; H, 7.77; N, 5.19.
Compound 4ba. Pale yellow oil. IR (cm−1, neat): 1070, 1177, 1479, 1616, 1723, 2975. 1H-NMR (CDCl3, 400 MHz) δ: 1.31 (t, 3H, J = 7.3 Hz), 1.45 (t, 3H, J = 7.3 Hz), 2.99 (q, 2H, J = 7.3 Hz), 4.51 (q, 2H, J = 7.3 Hz), 7.57–7.63 (m, 1H), 7.73-7.76 (m, 1H), 7.93 (s, 1H), 8.08 (d, 1H, J = 9.0 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.5, 15.2, 25.9, 62.4, 125.9, 129.7, 130.6, 131.6, 134.0, 135.5, 136.7, 144.3, 150.9, 166.8. GC-MS (70 eV): m/z: 263 ([M+], 26), 236 (25), 234 (71), 218 (15), 216 (16), 192 (30), 191 (54), 190 (100), 189 (59), 188 (57), 163 (19), 154 (52), 153 (14), 128 (14), 126 (18). Anal. Calcd. for C14H14ClNO2 (263.72): C, 63.76; H, 5.35; N, 5.31. Found: C, 63.80; H, 5.38; N, 5.27.
Compound 4bg. Pale yellow oil. IR (cm−1, neat): 1072, 1173, 1481, 1615, 1721, 2978. 1H-NMR (CDCl3, 400 MHz) δ: 1.46 (t, 3H, J = 7.3 Hz), 2.64 (s, 3H), 4.52 (q, 2H, J = 7.3 Hz), 7.60 (dd, 1H, J = 9.4, 2.6 Hz), 7.20 (d, 1H, J = 2.6 Hz), 7.91 (s, 1H), 8.09 (d, 1H, J = 8.6 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.5, 20.0, 62.3, 125.6, 129.6, 130.6, 131.3, 131.7, 134.2, 137.1, 144.4, 150.4, 166.6. GC-MS (70 eV): m/z: 249 ([M+], 9), 220 (18), 179 (31), 178 (15), 177 (100), 176 (18), 175 (18), 141 (24), 140 (40). Anal. Calcd. for C13H12ClNO2 (249.69): C, 62.53; H, 4.84; N, 5.61. Found: C, 62.50; H, 4.81; N, 5.58.
Compound 4ca. Pale brown oil. IR (cm−1, neat): 1057, 1126, 1435, 1633, 1730, 2977. 1H-NMR (CDCl3, 400 MHz) δ: 1.36 (t, 3H, J = 7.3 Hz), 1.47 (t, 3H, J = 7.3 Hz), 3.04 (q, 2H, J = 7.3 Hz), 4.54 (q, 2H, J = 7.3 Hz), 7.74 (d, 1H, J = 8.9 Hz), 7.92 (d, 1H, J = 8.9 Hz), 8.11 (s, 1H), 8.49 (s, 1H). 13C-NMR (CDCl3, 100MHz) δ: 14.4, 15.0, 25.8, 29.8, 32.9, 62.3, 121.3, 123.6, 123.7, 126.7, 127.8, 127.9, 128.0, 128.1, 128.4, 130.4, 131.0, 131.7, 136.0, 137.7, 144.9, 152.3, 166.6. GC-MS (70 eV): m/z: 297 ([M+], 21), 268 (82), 225 (36), 224 (100), 223 (66), 222 (96), 197 (21), 196 (14), 154 (31). Anal. Calcd. for C15H14F3NO2 (297.28): C, 60.61; H, 4.75; N, 4.71. Found: C, 60.57; H, 4.78; N, 4.68.
Compound 4dh. Yellow oil. IR (cm−1, neat): 1052, 1119, 1431, 1606, 1638, 1728, 2971. 1H-NMR (CDCl3, 400 MHz) δ: 1.46 (t, 3H, J = 7.3 Hz), 2.40–2.48 (m, 2H), 2.53 (s, 3H), 3.05-3.11 (m, 2H), 4.52 (q, 2H, J = 7.3 Hz), 4.97–5.07 (m, 2H), 5.80–5.93 (m, 1H), 7.50–7.55 (m, 2H), 7.94 (s, 1H), 8.09 (d, 1H, J = 9.4 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 14.5, 22.0, 32.4, 35.3, 62.3, 115.9, 126.0, 129.1, 129.5, 132.2, 133.7, 137.2, 137.6, 138.6, 144.5, 149.2, 166.9. GC-MS (70 eV): m/z: 264 (7), 235 (14), 197 (37), 193 (100), 191 (50), 177 (11), 142 (11), 30 (10). Anal. Calcd. for C17H19NO2 (269.34): C, 75.81; H, 7.11; N, 5.20. Found: C, 75.77; H, 7.08; N, 5.22.
Compound 4di. Yellow oil. IR (cm−1, neat): 697, 825, 1076, 1170, 1286, 1455, 1492, 1626, 1724, 2967. 1H-NMR (CDCl3, 400 MHz) δ: 1.25 (t, 3H, J = 7.3 Hz), 2.53 (s, 3H), 2.96 (t, 2H, J = 7.3 Hz), 5.51 (s, 2H), 7.31–7.42 (m, 3H), 7.48–7.56 (m, 4H), 7.94 (s, 1H), 8.07 (d, 1H, J = 8.5 Hz). 13C-NMR (CDCl3, 100 MHz) δ: 15.4, 22.0, 25.9, 67.8, 126.0, 128.6, 128.8, 128.9, 129.3, 129.6, 132.1, 135.8, 135.9, 136.0, 138.5, 144.5, 149.2, 166.9. GC-MS (70 eV): m/z: 210 (24), 196 (18), 168 (100), 167 (75), 165 (31), 152 (19), 141 (18), 114 (14), 90 (73), 65 (28). Anal. Calcd. for C20H19NO2 (305.38): C, 78.66; H, 6.27; N, 4.59. Found: C, 78.69; H, 6.24; N, 4.62.

Acknowledgments

The authors thank the University of Camerino for financial support.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
TMG
1,1,3,3-Tetramethylguanidine
DBU
1,5-Diazabiciclo[5.4.0]undec-5-ene
BEMP
2-tert-Butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine
TBD
1,5,7-Triazabicyclo[4.4.0]dec-5-ene

References and Note

  1. Marella, A.; Tanwar, O.P.; Saha, R.; Ali, M.R.; Srivastava, S.; Akhter, M.; Shaquiquzzaman, M.; Alam, M.M. Quinoline: A versatile heterocyclic. Saudi Pharm. J. 2013, 21, 1–12. [Google Scholar] [CrossRef] [PubMed]
  2. Afzal, O.; Kumar, S.; Haider, M.R.; Ali, M.R.; Kumar, R.; Jaggi, M.; Bawa, S. A review on anticancer potential of bioactive heterocycle quinoline. Eur. J. Med. Chem. 2015, 97, 871–910. [Google Scholar] [CrossRef] [PubMed]
  3. Prajapati, S.M.; Patel, K.D.; Vekariya, R.H.; Panchal, S.N.; Patel, H.D. Recent advances in the synthesis of quinolines: A review. RSC Adv. 2014, 4, 24463–24476. [Google Scholar] [CrossRef]
  4. Ciufolini, M.A.; Roschangar, F. Practical total synthesis of (+)-camptothecin: The full story. Tetrahedron 1997, 53, 11049–11060. [Google Scholar] [CrossRef]
  5. Manfredini, S.; Vertuani, S.; Pavan, B.; Vitali, F.; Scaglianti, M.; Bortolotti, F.; Biondi, C.; Scatturin, A.; Prasad, P.; Dalpiaz, A. Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules. Bioorg. Med. Chem. 2004, 12, 5453–5463. [Google Scholar] [CrossRef] [PubMed]
  6. Nayyar, A.; Monga, V.; Malde, A.; Coutinhob, E.; Jaina, R. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines. Bioorg. Med. Chem. 2007, 15, 626–640. [Google Scholar] [CrossRef] [PubMed]
  7. Horchler, C.L.; McCauley, J.P.; Hall, J.E.; Snyder, D.H.; Moore, W.C.; Hudzik, T.J.; Chapdelaine, M.J. Synthesis of novel quinoline and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl)amides: A late-stage diversification approach to potent 5HT1B antagonists. Bioorg. Med. Chem. 2007, 15, 939–950. [Google Scholar] [CrossRef] [PubMed]
  8. Contour-Galcéra, M.-O.; Sidhu, A.; Plas, P.; Roubert, P. 3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists. Bioorg. Med. Chem. Lett. 2005, 15, 3555–3559. [Google Scholar] [CrossRef] [PubMed]
  9. Saburi, H.; Tanaka, S.; Kitamura, M. Catalytic dehydrative allylation of alcohols. Angew. Chem. Int. Ed. 2005, 44, 1730–1732. [Google Scholar] [CrossRef] [PubMed]
  10. Tanaka, S.; Saburi, H.; Ishibashi, Y.; Kitamura, M. CpRuIIPF6/Quinaldic Acid-Catalyzed Chemoselective Allyl Ether Cleavage. A Simple and Practical Method for Hydroxyl Deprotection. Org. Lett. 2004, 6, 1873–1875. [Google Scholar] [CrossRef] [PubMed]
  11. Tagawa, Y.; Yamashita, K.; Higuchi, Y.; Goto, Y. Improved oxidation of active methyl group of N-heteroaromatic compounds by selenium dioxide in the presence of tert-butyl hydroperoxide. Heterocycles 2003, 60, 953–957. [Google Scholar] [CrossRef]
  12. George, I.R.; Lewis, W.; Moody, C.J. Synthesis of iodopyridone. Tetrahedron 2013, 69, 8209–8215. [Google Scholar] [CrossRef]
  13. Shrader, W.D.; Celebuski, J.; Kline, S.J.; Johnson, D. Synthesis of a novel hexadentate chelating agent based on8-hydroxyquinoline. Tetrahedron Lett. 1988, 29, 1351–1354. [Google Scholar] [CrossRef]
  14. Huang, H.; Jiang, H.; Chen, K.; Liu, H. A Simple and convenient copper-catalyzed tandem synthesis of quinoline-2-carboxylates at room temperature. J. Org. Chem. 2009, 74, 5476–5480. [Google Scholar] [CrossRef] [PubMed]
  15. Rohlmann, R.; Stopka, T.; Richter, H.; Mancheño, O.G. Iron-catalyzed oxidative tandem reactions with TEMPO oxoammonium salts: Synthesis of dihydroquinazolines and quinolines. J. Org. Chem. 2013, 78, 6050–6064. [Google Scholar] [CrossRef] [PubMed]
  16. Bass, J.Y.; Caravella, J.A.; Chen, L.; Creech, K.L.; Deaton, D.N.; Madauss, K.P.; Marr, H.B.; McFadyen, R.B.; Miller, A.B.; Mills, W.Y.; et al. Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene. Bioorg. Med. Chem. Lett. 2011, 21, 1206–1213. [Google Scholar] [CrossRef] [PubMed]
  17. Ciufolini, M.A.; Mitchell, J.W.; Rosehangar, F. Facile palladium-mediated substitution of chlorine in 2-chloroquinolines. Tetrahedron Lett. 1996, 37, 8281–8284. [Google Scholar] [CrossRef]
  18. Itoh, S.; Fukui, Y.; Haranou, S.; Ogino, M.; Komatau, M.; Ohshiro, Y. Synthesis and characterization of dimethyl 9,10-dihydro-9,10-dioxobenzo[f]quinoline-2,4-dicarboxylate. Effect of the pyrrole nucleus on the reactivity of coenzyme PQQ. J. Org. Chem. 1992, 57, 4452–4457. [Google Scholar] [CrossRef]
  19. Ballini, R.; Palmieri, A.; Talaq, M.A.; Gabrielli, S. Preparation of 2H-1,4-benzoxazin-2-one derivatives under heterogeneous conditions via domino process. Adv. Synth. Catal. 2009, 351, 2611–2614. [Google Scholar] [CrossRef]
  20. Ballini, R.; Gabrielli, S.; Palmieri, A. β-Nitroacrylates as key starting materials for the uncatalysed one-pot synthesis of polyfunctionalized dihydroquinoxalinone derivatives, via an anti-Michael reaction. Synlett 2009, 2009, 965–967. [Google Scholar] [CrossRef]
  21. Ballini, R.; Bosica, G.; Gabrielli, S.; Palmieri, A. β -Nitroacrylates and silyl enol ethers as key starting materials for the synthesis of polyfunctionalized β-nitro esters and 1,2-oxazine-2-oxides. Tetrahedron 2009, 65, 2916–2920. [Google Scholar] [CrossRef]
  22. Ballini, R.; Gabrielli, S.; Palmieri, A. β-Nitroacrylates as precursors of tetrasubstituted furans in a one-pot process and under acidic solvent-free conditions. Synlett 2010, 2010, 2468–2470. [Google Scholar] [CrossRef]
  23. Palmieri, A.; Gabrielli, S.; Lanari, D.; Vaccaro, L.; Ballini, R. A new one-pot synthesis of polysubstituted indoles from pyrroles and β-nitroacrylates. Adv. Synth. Catal. 2011, 353, 1425–1428. [Google Scholar] [CrossRef]
  24. Palmieri, A.; Gabrielli, S.; Cimarelli, C.; Ballini, R. Fast, mild, eco-friendly synthesis of polyfunctionalized pyrroles from β-nitroacrylates and β-enaminones. Green Chem. 2011, 13, 3333–3336. [Google Scholar] [CrossRef]
  25. Gabrielli, S.; Ballini, R.; Palmieri, A. β-Nitroacrylates as key building blocks for the synthesis of alkyl 3-substituted 5-oxopiperazine-2-carboxylates under fully heterogeneous conditions. Mon. Chem. 2013, 144, 509–514. [Google Scholar] [CrossRef]
  26. Palmieri, A.; Gabrielli, S.; Maggi, R.; Ballini, R. β-Nitroacrylates as useful building blocks for the synthesis of alkyl indole-2-carboxylates. Synlett 2014, 25, 128–132. [Google Scholar] [CrossRef]
  27. Palmieri, A.; Gabrielli, S.; Parlapiano, M.; Ballini, R. One-pot synthesis of alkyl pyrrole-2-carboxylates starting from β-nitroacrylates and primary amines. RSC Adv. 2015, 5, 4210–4213. [Google Scholar] [CrossRef]
  28. Castaing, M.; Wason, S.L.; Estepa, B.; Hooper, J.F.; Willis, M.C. 2-Aminobenzaldehydes as versatile substrates for rhodium-catalyzed alkyne hydroacylation: Application to dihydroquinoline synthesis. Angew. Chem. Int. Ed. 2013, 52, 13280–13283. [Google Scholar] [CrossRef] [PubMed]
  29. Haddadin, M.J.; Bou Zerdan, R.M.; Kurth, M.J.; Fettinger, J.C. Efficient syntheses of the unknown quinolino[2,3-c]cinnolines; synthesis of neocryptolepines. Org. Lett. 2010, 12, 5502–5505. [Google Scholar] [CrossRef] [PubMed]
  30. Ballini, R.; Fiorini, D.; Palmieri, A. Nitroalkanes and ethyl glyoxalate as common precursors for the preparation of both β-keto esters and α,β-unsaturated esters. Tetrahedron Lett. 2004, 45, 7027–7029. [Google Scholar] [CrossRef]
  31. Palmieri, A.; Gabrielli, S.; Ballini, R. Low impact synthesis of β-nitroacrylates under fully heterogeneous conditions. Green Chem. 2013, 15, 2344–2348. [Google Scholar] [CrossRef]
  32. The BEMP on polymer support was purchased from Sigma–Aldrich (code 536490) and used directly without any manipulation.
  • Sample Availability: Samples of the compounds 4 are available from the authors.
Scheme 1. Main synthetic approaches for synthesizing quinoline-2-carboxylate derivatives.
Scheme 1. Main synthetic approaches for synthesizing quinoline-2-carboxylate derivatives.
Molecules 21 00776 sch001
Scheme 2. Synthetic approach for synthesizing quinoline-2-carboxylate derivatives 4.
Scheme 2. Synthetic approach for synthesizing quinoline-2-carboxylate derivatives 4.
Molecules 21 00776 sch002
Scheme 3. Synthesis of starting materials 1 and 2.
Scheme 3. Synthesis of starting materials 1 and 2.
Molecules 21 00776 sch003
Scheme 4. One-pot process.
Scheme 4. One-pot process.
Molecules 21 00776 sch004
Scheme 5. One-pot reaction products.
Scheme 5. One-pot reaction products.
Molecules 21 00776 sch005
Table 1. Optimization studies concerning the “aza-Michael-Henry domino process”.
Table 1. Optimization studies concerning the “aza-Michael-Henry domino process”.
Molecules 21 00776 i001
Entry1a (mmol)2a (mmol)SolventTemp. (°C)Time (h)Yield (%) 1
Entry 111-r.t.24Traces
Entry 211-502444
Entry 311-602451
Entry 411-701861
Entry 511-801852
Entry 61.11-701859
Entry 711.1-701866
Entry 811.2-701864
Entry 911.1MeCN701811
Entry 1011.1EtOAc70189
Entry 1111.1-701821 2
Entry 1211.1-70188 3
1 Yield of pure isolated product; 2 The reaction was performed in the presence of 1 eq. of TMG; 3 The reaction was performed in the presence of 1 eq. of Et3N.
Table 2. Optimization studies concerning aromatization step.
Table 2. Optimization studies concerning aromatization step.
Molecules 21 00776 i002
EntryBase (eq.)SolventTemp. (°C)Time (h)Yield (%) 1
Entry 1TMG (1)MeCN502447
Entry 2DBU (1)MeCN502436
Entry 3Amberlyst A21 (1)MeCN5024Traces
Entry 4TBD on polymer (1)MeCN502462
Entry 5Carbonate on polymer (1)MeCN502457
Entry 6BEMP on polymer (1)MeCN502479
Entry 7BEMP on polymer (0.8)MeCN502467
Entry 8BEMP on polymer (1.25)MeCN502486
Entry 9BEMP on polymer (1.5)MeCN502482
Entry 10BEMP on polymer (1.25)MeCN402469
Entry 11BEMP on polymer (1.25)MeCN602485
Entry 12BEMP on polymer (1.25)EtOAc502471
Entry 13BEMP on polymer (1.25)2-MeTHF502447
Entry 14BEMP on polymer (1.25)Toluene50 2439
1 Yield of pure isolated product.

Share and Cite

MDPI and ACS Style

Gabrielli, S.; Giardinieri, A.; Sampaolesi, S.; Ballini, R.; Palmieri, A. A New One-Pot Synthesis of Quinoline-2-carboxylates under Heterogeneous Conditions. Molecules 2016, 21, 776. https://doi.org/10.3390/molecules21060776

AMA Style

Gabrielli S, Giardinieri A, Sampaolesi S, Ballini R, Palmieri A. A New One-Pot Synthesis of Quinoline-2-carboxylates under Heterogeneous Conditions. Molecules. 2016; 21(6):776. https://doi.org/10.3390/molecules21060776

Chicago/Turabian Style

Gabrielli, Serena, Alessandra Giardinieri, Susanna Sampaolesi, Roberto Ballini, and Alessandro Palmieri. 2016. "A New One-Pot Synthesis of Quinoline-2-carboxylates under Heterogeneous Conditions" Molecules 21, no. 6: 776. https://doi.org/10.3390/molecules21060776

Article Metrics

Back to TopTop